T1	Participants 105 113	children
T2	Participants 416 422	adults
T3	Participants 496 513	children with PAH
T4	Participants 543 601	29 children treated with inhaled treprostinil for â‰¥6 weeks
T5	Participants 982 1061	discontinued in 4 patients because of symptoms including cough and bronchospasm
T6	Participants 1686 1709	PAH therapy in children
T7	Participants 1834 1861	pediatric patients with PAH
